問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital (在職)

Division of Colorectal Surgery

更新時間:2023-09-19

黃晟瑋
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

3Cases

2025-06-25 - 2030-03-31

Phase II

Not yet recruiting
A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects with Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)
  • Condition/Disease

    ctDNA-positive colorectal cancer (CRC)

  • Test Drug

    ABBV-400

Participate Sites
3Sites

Recruiting3Sites

2022-08-31 - 2026-02-28

Phase III

Active
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
  • Condition/Disease

    Colorectal Cancer

  • Test Drug

    XL092

Participate Sites
6Sites

Recruiting6Sites

2023-12-22 - 2030-10-25

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites